Long-Term Treatment with Fluvoxamine Decreases Nonmotor Symptoms and Dopamine Depletion in a Postnatal Stress Rat Model of Parkinson’s Disease
Nonmotor symptoms (NMS) such as anxiety, depression, and cognitive deficits are frequently observed in Parkinson’s disease (PD) and precede the onset of motor symptoms by years. We have recently explored the short-term effects of Fluvoxamine, a selective serotonin reuptake inhibitor (SSRI) on dopami...
Main Authors: | Ernest Dallé, William M. U. Daniels, Musa V. Mabandla |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2020/1941480 |
Similar Items
-
Dopamine-Induced Nonmotor Symptoms of Parkinson's Disease
by: Ariane Park, et al.
Published: (2011-01-01) -
Nonmotor Symptoms of Parkinson's Disease
by: Irena Rektorova, et al.
Published: (2011-01-01) -
Nonmotor Symptoms of Parkinson’s Disease
by: Shey-Lin Wu, et al.
Published: (2017-01-01) -
Evaluation of Nonmotor Symptoms in Diagnosis of Parkinsonism and Tremor
by: Andrew H. Evans, et al.
Published: (2016-01-01) -
Neuropathology and Neurochemistry of Nonmotor Symptoms in Parkinson's Disease
by: Isidro Ferrer
Published: (2011-01-01)